tirzepatide vs semaglutide weight loss efficacy for Tirzepatide as Compared with Semaglutide

Stein K, Maruf AA, Mller DJ, Bishop JR, Bousman CA

All studies were blinded and placebo-controlled

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are now widely used in the treatment of patients with type 2 diabetes (T2D)

This includes reviewing blood sugar levels for semaglutide and symptom control for Vyvanse

Long-Term Therapy The decision to continue, reduce, or stop semaglutide should be guided by four factors: your weight-regain rate during any previous treatment breaks, your genetic predisposition (revealed through peptide pathway testing), the lifestyle changes you've successfully implemented, and your metabolic health markers

INCREASE METABOLIC FUNCTION GLP-1s maintain optimal blood sugar levels by boosting insulin and minimizing glucagon whenever glucose levels rise